• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
ALA

AROVELLA THERAPEUTICS LIMITED

0.00% ! 10.0¢
Market Cap $106.4M  !

Arovella Therapeutics Limited is a biotechnology company. The Company is focused on... Arovella Therapeutics Limited is a biotechnology company. The Company is focused on developing its invariant natural killer T (iNKT) cell therapy platform from Imperial College London to treat blood cancers and solid tumors. The Company's lead product is ALA-101. ALA-101 is being developed as an allogeneic cell therapy, which means it can be given from a healthy donor to a patient. ALA-101 is a next-generation CAR-iNKT cell therapy that targets CD19+ B cell lymphomas and leukemias. ALA-101 consists of CAR19-iNKT cells that have been modified to produce a Chimeric Antigen Receptor (CAR) that targets CD19. CD19 is an antigen found on the surface of numerous cancer types. The Company is also engaged in expanding solid tumor treatment through its CLDN18.2-targeting technology licensed from Sparx Group. Its iNKT cells also contain an invariant T cell receptor (iTCR) that targets alpha-galactosylceramide (a-GalCer) bound CD1d, another antigen found on the surface of several cancer types.More

HELPING PATIENTS ON THEIR JOURNEY TO BETTER HEALTH

Little Green Pharma (ASX:LGP) to benefit as Denmark commits to cannabis pilot program.

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
ALA
ALA - technical setup
16/03/25 8 2.2K
16/03/25 Last post  abitlikeme Comments Created with Sketch.  8  Views Created with Sketch.  2.2K 
ALA 10/03/25 33 11K
10/03/25 Last post  marty1207 Comments Created with Sketch.  33  Views Created with Sketch.  11K 
ALA 07/03/25 0 437
07/03/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  437 
ALA 05/03/25 0 384
05/03/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  384 
ALA 05/03/25 0 217
05/03/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  217 
ALA 05/03/25 0 270
05/03/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  270 
ALA 03/03/25 42 15K
03/03/25 Last post  bubsmark Comments Created with Sketch.  42  Views Created with Sketch.  15K 
ALA 03/03/25 0 402
03/03/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  402 

See All Discussions arrow Created with Sketch.

Timeline

S&P DJI Announces March 2025 Quarterly Rebalance
07 Mar 17:01
 
Top 20 Holders and Range of Units for Attaching Options
05 Mar 11:59
 
Application for quotation of securities - ALA
05 Mar 11:55
 
Application for quotation of securities - ALA
05 Mar 10:01
 
Research Agreement with University of North Carolina
03 Mar 12:34
 
Letter from Managing Director and CEO
03 Mar 12:12
 
View More arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
10.0¢
Change
0.000(0.00%)
Mkt cap ! $106.4M
Open High Low Value Volume
10.0¢ 10.3¢ 10.0¢ $67.63K 669.9K

Buyers (Bids)

No. Vol. Price($)
12 932390 10.0¢
 

Sellers (Offers)

Price($) Vol. No.
10.5¢ 776556 9
View Market Depth
Last trade - 16.10pm 14/03/2025 (20 minute delay) ?
ALA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.